<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>M protein mutant vesicular <z:hpo ids='HP_0010280'>stomatitis</z:hpo> virus is an attractive candidate oncolytic virus for the treatment of <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> due to its ability to kill <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells that are defective in their antiviral responses </plain></SENT>
<SENT sid="1" pm="."><plain>The oncolytic activity of recombinant <z:mp ids='MP_0002169'>wild-type</z:mp> and M protein mutant vesicular <z:hpo ids='HP_0010280'>stomatitis</z:hpo> viruses was determined in RKO, Hct116 and LoVo <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, as well as in human fibroblast and hepatocyte primary cultures </plain></SENT>
<SENT sid="2" pm="."><plain>RKO and Hct116 cells were sensitive to both viruses, whereas LoVo cells were resistant </plain></SENT>
<SENT sid="3" pm="."><plain>[(35)S]methionine labeling experiments and <z:mp ids='MP_0001799'>viral</z:mp> plaque assays showed that sensitive and resistant <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells supported <z:mp ids='MP_0001799'>viral</z:mp> protein and progeny production after <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with either virus </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> cells were pretreated with Î²-interferon and infected with vesicular <z:hpo ids='HP_0010280'>stomatitis</z:hpo> virus to evaluate the extent to which interferon signaling is downregulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Although <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells retained some degree of interferon signaling, this signaling did not negatively impact the oncolytic effects of either virus in sensitive cells </plain></SENT>
<SENT sid="6" pm="."><plain>Murine xenografts of RKO cells were effectively treated by intratumoral injections with M protein mutant virus, whereas LoVo xenografts were resistant to treatment with this virus </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that M protein mutant vesicular <z:hpo ids='HP_0010280'>stomatitis</z:hpo> virus is a good candidate oncolytic virus for the treatment of selected <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancers</z:e> </plain></SENT>
</text></document>